Pharmacodynamics of a contraceptive vaginal ring releasing norethindrone and estradiol: Ovarian function, bleeding control and lipoprotein patterns
- 1 February 1985
- journal article
- Published by Elsevier in Contraception
- Vol. 31 (2) , 131-140
- https://doi.org/10.1016/0010-7824(85)90026-5
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Ovarian function, bleeding control and serum lipoproteins in women using contraceptive vaginal rings releasing five different progestinsContraception, 1983
- Lipoprotein patterns in women in Santo Domingo using a levonorgestrel/estradiol contraceptive ringContraception, 1981
- Comparison of the metabolic effects of two hormonal contraceptive methods: An oral formulation and a vaginal ring II. Serum lipoproteins and apolipoproteinsContraception, 1981
- The effect on lipids and lipoproteins of a contraceptive vaginal ring containing levonorgestrel and estradiolContraception, 1981
- A multicenter study of levonorgestrel—Estradiol contraceptive vaginal rings III — Menstrual patternsContraception, 1981
- A multicenter study of levonorgestrel—Estradiol contraceptive vaginal rings I — Use effectivenessContraception, 1981
- Levonorgestrel and estradiol release from an improved contraceptive vaginal ringContraception, 1981
- The Tromsø Heart Study: Serum apolipoprotein Al concentration in relation to future coronary heart diseaseEuropean Journal of Clinical Investigation, 1978
- High density lipoprotein as a protective factor against coronary heart diseaseThe American Journal of Medicine, 1977
- The effect of various dosages of lynestrenol on the plasma levels of oestrogens and progesterone during the menstrual cycle in the rhesus monkeyContraception, 1976